Kawasaki disease complicated by macrophage activation syndrome treated with canakinumab
Journal of Human Immunity · 06.07.2026 · 2 (4)
DOI: 10.70962/jhi.20250240 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Human Immunity, online erschienen am 09.04.2026. Verfasst von Stejara A Netea und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center, University o…. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: SK Foundation, Dutch Foundation Fonds Kind … Handicap.
Abstract (Originalsprache)
An infant presented with macrophage activation syndrome as part of Kawasaki disease, and was first treated with canakinumab, followed by methylprednisolone and IVIG. Despite early treatment, giant coronary artery aneurysms developed transiently, questioning the singular role of IL-1 in KD.
Autor:innen und Institutionen
- Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
- Department of Experimental Immunology, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
- Pediatric Cardiology, Emma Children's Hospital, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
- Department of Blood Cell Research, Sanquin Research Institute, University of Amsterdam, Amsterdam, The Netherlands.
ORCID-Profile: Stejara A Netea, Diana van Stijn, Mariken P Gruppen, J Merlijn van den Berg, Nico A Blom, Irene M Kuipers, Taco W Kuijpers
Förderung
- SK Foundation
- Dutch Foundation Fonds Kind … Handicap
Zitieren
APA
Netea, S. A., van Stijn, D., Gruppen, M. P., van den Berg, J. M., Blom, N. A., Kuipers, I. M., & Kuijpers, T. W. (2026). Kawasaki disease complicated by macrophage activation syndrome treated with canakinumab. Journal of Human Immunity, 2(4). https://doi.org/10.70962/jhi.20250240
Vancouver
Netea SA, van Stijn D, Gruppen MP, van den Berg JM, Blom NA, Kuipers IM, et al. Kawasaki disease complicated by macrophage activation syndrome treated with canakinumab. Journal of Human Immunity. 2026;2(4). doi:10.70962/jhi.20250240
BibTeX
@article{Netea2026,
author = {Netea, Stejara A and van Stijn, Diana and Gruppen, Mariken P and van den Berg, J Merlijn and Blom, Nico A and Kuipers, Irene M and Kuijpers, Taco W},
title = {Kawasaki disease complicated by macrophage activation syndrome treated with canakinumab},
journal = {Journal of Human Immunity},
year = {2026},
volume = {2},
number = {4},
doi = {10.70962/jhi.20250240}
}
EUVIMED